1910 Genetics
MA - BostonBiotechnology
Focus: 1910 Genetics operates a computational chemistry platform for discovering and developing small molecule therapeutics across ophthalmology, neurology, and gastroenterology. The company is pre-clinical stage with a technology-first approach to drug discovery.
Profile data last refreshed 5h ago · AI intelligence enriched 2w ago
Open Jobs
6
Should You Work at 1910 Genetics?
AI assessment1910 Genetics is a technology-centric discovery platform best suited for computational scientists seeking early-stage risk/reward; career growth depends entirely on unannounced funding and pipeline advancement.
Why Work Here
- Join a computational chemistry platform at the frontier of AI-driven drug discovery, offering deep technical expertise in physics-based modeling and small molecule design
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for 1910 Genetics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.